Charles N Landen

Affiliations reported with papers

Linked publications

A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors 2021

A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer 2018

Related research

FOLR1-anchored DR5 bispecific antibody

Surface charge and DR5 antibody response